Effects of valsartan on fibrinolysis in hypertensive patients with metabolic syndrome.
Miyata M, Ikeda Y, Nakamura S, Sasaki T, Abe S, Minagoe S, Torii H, Lee S, Tateishi S, Kihara K, Ohba I, Kajiya S, Furusho Y, Hamasaki S, Tei C; Kagoshima Collaborate Trial in Metabolic Syndrome (KACT-MetS) Investigators.
Miyata M, et al. Among authors: kajiya s.
Circ J. 2012;76(4):843-51. doi: 10.1253/circj.cj-12-0153.
Circ J. 2012.
PMID: 22451451
Free article.
Clinical Trial.